Delivery Order SPE2DB25D3110-SPE2DB25FTEBL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,342.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency has awarded a delivery order valued at $1,691.15 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens. The order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,304.68 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed-price, non-set-aside delivery order represents a purchase of pharmaceutical inventory to support military and federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the federal government...
- The Defense Logistics Agency awarded a $3,892.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This non-competitive delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.38 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price, non-set-aside delivery order represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens, with a contract ceiling value of $9,796.98 and an ultimate completion date of August 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,051.05. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,458.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger contract vehicle and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Trulicity is a prescription diabetes medication commonly used within military...
- The Defense Logistics Agency awarded a delivery order valued at $7,416.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEBLDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,862.58 on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 12, 2025, and performance executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor. The company maintains an extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain, supplying a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for Trulicity, a diabetes medication, exemplifies the company's ongoing support for military and veteran healthcare requirements through the DLA's pharmaceutical procurement initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/11/25 |